Ann: THC: Secures Additional Site for Medicinal Cannabis Growth, page-12

In layman’s we get access to a sweet companies access for providing what appears to be not a hell of a lot in return. There’s no acquisition that I can read which is excellent. EVE of course holds 50%. But this really moves meluka to more of a forefront position because now they have access to plant and production once thc completes licencing. THC is up there with AC8 and I think this should really boost Meluka in their direction. Not to say that they will price point match or come close; but the capabilities of these companies combined create a great force to start looking to compete on some levels with ac8/cann.

Anyways just my 2c. GLTAH DYOR.